We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MannKind Beset With Afrezza Clinical Trial Fraud Allegations
MannKind Beset With Afrezza Clinical Trial Fraud Allegations
November 12, 2010
Less than two months before the FDA makes a decision on its inhaled insulin Afrezza, MannKind is facing allegations of clinical trial improprieties from a former employee.